Loading...
Correlation of an Index-Lesion-Based SPECT Dosimetry Method with Mean Tumor Dose and Clinical Outcome after (177)Lu-PSMA-617 Radioligand Therapy
Background: Dosimetry can tailor prostate-specific membrane-antigen-targeted radioligand therapy (PSMA-RLT) for metastatic castration-resistant prostate cancer (mCRPC). However, whole-body tumor dosimetry is challenging in patients with a high tumor burden. We evaluate a simplified index-lesion-base...
Na minha lista:
| Udgivet i: | Diagnostics (Basel) |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7999994/ https://ncbi.nlm.nih.gov/pubmed/33802417 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics11030428 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|